Mononuclear Cells – Chronic Obstructive Pulmonary Disease (COPD)

$850.00

Source:

Status:

Disease:

Purity:

Viability:

Contains:

For a custom order, contact us or click here to customize.

Select Format

Please specify a format to review quotes

10 x 106 PB009C-1-COPD
$850.00 Cryopreserved
Add to cart
Total:
SKU:

Description

Product Overview:

Chronic Obstructive Pulmonary Disease (COPD) is a lung disease associated with shortness of breath and coughing due to poor airflow in the lungs. COPD is a progressive disease that ultimately limits the physical activities of those who suffer from it. Multiple factors contribute to COPD, including smoking, air pollution, and exposure to airborne irritants.

High-quality samples are paramount in developing new treatments for COPD. HemaCare sources, isolates, and ships human samples under rigorously controlled protocols to provide the optimum starting material for your research.

Patients diagnosed with COPD are recruited as donors for research products. They review and sign an independent biomedical review board (IRB) approved procedure-specific consent form prior to the collection.

Storage Conditions:

Either prepare cells for long-term storage in Liquid Nitrogen vapor phase or thaw for use. Storage in liquid phase nitrogen is NOT recommended. Short-term storage of cells (less than 2 weeks) at -80°C is acceptable but should be minimized to ensure maximum stability. Once thawed, samples must be used immediately.

Testing:

Donors are tested for HBV, HCV, and HIV, unless requested otherwise.

PBMC Flow Data

Please note that the frequency of cell type via principal markers is highly variable and can be significantly influenced by the type of disease, medication prescribed to the donor, and how the donor reacts to the medication. These graphs and their subsequent cell frequencies are representative sample and are not indicative of received samples.

CD45 versus PI flow data
CD45 and Propidium Iodide (PI) are used to assess purity and viability of PBMCs. CD45 is expressed on all leukocytes and is used to indicate purity of the white blood cell (WBC) component. Because PI cannot pass through the membrane of live cells to stain DNA, it serves as an indicator of viability. Representative data shown here indicates purity of 95.09% – meaning >95% of cells in this sample are WBCs. (May not be indicative of received samples.)

CD45 versus CD3 flow data
CD3 is a multimeric surface molecule expressed commonly by T cell populations. Assessing CD3 versus CD45 helps enumerate what percentage of white blood cells within the sample are T cells. Representative data shown here indicates a relative T cell population of 48.31%. (May not be indicative of received samples.)

CD8 versus CD4 flow data
CD4 and CD8 are co-receptors that can be used to distinguish the two major classes of T cells – helper and cytotoxic, respectively. The ratio of CD4 and CD8 cells can be used as a marker of immune activation and immune senescence. Representative data indicates a typical CD4/CD8 ratio that is around 2 but may vary depending on the health of donor. (May not be indicative of received samples.)

CD45 versus CD14 flow data
CD14 is a marker expressed on multiple cell types, including monocytes, macrophages, and neutrophils. Assessing CD14 versus CD45 within the mononuclear cell component of peripheral blood will enumerate what percentage of the sample are monocytes. Representative data illustrates a relative monocyte population of 24.06%. (May not be indicative of received samples.)

CD45 versus CD19 flow data
CD19 is one of the proteins found in the B-cell co-receptor complex. It can be used as a marker for the identification and quantification of B cells within the sample. Assessing CD19 vs. CD45 will enumerate what percentage of the white blood cells within the sample are B cells. Representative data illustrates a relative B cell population of 12.93%. (May not be indicative of received samples.)

CD45 versus CD56 flow data
CD56 or neural cell adhesion molecule (NCAM) is a homophilic binding glycoprotein expressed on the surface of natural killer (NK) cells. It can be used to identify the relative frequency of NK cells within the white blood cell (WBC) population. Assessing CD56 vs. CD45 will enumerate what percentage of the WBCs within the sample are NK cells. Representative data illustrates a relative NK cell population of 12.34%. (May not be indicative of received samples.)

Certificate of Analysis

Cryopreserved Disease-State Peripheral Blood Mononuclear Cells (PBMCs)
Disease-State Peripheral Blood Mononuclear Cells (PBMCs) Donor Profile

Protocols

How to Thaw Cryopreserved Cells